Abzu is a biotechnology company that develops AI-powered solutions for RNA drug discovery and development, focusing on RNA therapeutics like siRNAs, ASOs, and anti-miRs. Their platform leverages explainable, trustworthy AI to program and optimize drug candidates, minimizing experimental cycles and reducing cost and time-to-candidate. It is designed for pharmaceutical R&D teams seeking advanced methods for RNA drug design and delivery.
Visit Abzu's official website for product details and getting started.